Rhona Banks

Rhona is Veterinary Biologicals Consultant, RA-ELECT LTD, UK

  • Session Chair Emily Drury

    VM1: Availability and Innovation - under a new VMP legislation


    The requirements for quality data for LM products have increased under the new Regulation. It is difficult to determine which regulatory framework is most appropriate for novel ATMs.

  • AdobeStock_141017599
    Meeting Report

    VM1: Regulatory science – focus on biologicals


    Opening the session, Ivo Claassen spoke about the unprecedented situation of the COVID-19 pandemic and the effects it has had on regulatory adaptation and emergency response preparedness. It was remarkable that novel mRNA vaccines for humans were developed and licensed in such a short period. He believes that there will be a considerable impact on the regulatory landscape in the long term.